EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation Matters: How Cream Architecture Governs High-Dose Topical Melatonin

Federica Ruocco, Sergio A. Sánchez-Guirales, Raquel Fernández-García, Alejandro Romero, Antonio Juberías, Dolores R. Serrano, Juan J. Torrado

Gels · 19.11.2026 · 12 (11) · 1050

DOI: 10.3390/gels12111050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 19.11.2026. Verfasst von Federica Ruocco und 6 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Complutense University of Madrid Research Group: Formulation and Bioavailability of Drugs.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topical semisolid formulations containing more than 2.5% of melatonin (MT) are potential candidates for preventing or treating irritant-induced skin injuries. In this work, two different types of semisolid formulations based on either conventional Lanette® wax cream formulations or Pemulen® cream-gel systems were compared. The effect of inclusion of hydroxypropyl-ß-cyclodextrins (HP-ß-CD) was also studied. The following characteristics of the formulations were evaluated: internal particle size, syneresis, rheometer characteristics, extensibility, physical and chemical MT stability, dissolution release, bioadhesion, and porcine ear skin permeability. Under the experimental conditions evaluated, Pemulen® cream-gels exhibited significantly greater syneresis, lower viscosity, poorer physical stability, faster drug release, and higher permeability than conventional Lanette® wax creams (p < 0.05). Incorporation of HP-β-CD reduced spreadability (p < 0.01) while enhancing bioadhesion and chemical stability (p < 0.05). Higher viscosity was also associated with improved chemical stability (p = 0.03). These findings support tailoring the formulation to its intended application. The slower release provided by Lanette® creams and the higher permeability of Lanette® cream-gels indicate different MT delivery profiles. The suitability of these formulations for preventing or treating irritant-induced skin injury requires confirmation in appropriate skin models or clinical studies.

Förderung

  • Complutense University of Madrid Research Group: Formulation and Bioavailability of Drugs

Zitieren

APA

Ruocco, F., Sánchez-Guirales, S. A., Fernández-García, R., Romero, A., Juberías, A., Serrano, D. R., & Torrado, J. J. (2026). Formulation Matters: How Cream Architecture Governs High-Dose Topical Melatonin. Gels, 12(11), 1050. https://doi.org/10.3390/gels12111050

Vancouver

Ruocco F, Sánchez-Guirales SA, Fernández-García R, Romero A, Juberías A, Serrano DR, et al. Formulation Matters: How Cream Architecture Governs High-Dose Topical Melatonin. Gels. 2026;12(11):1050. doi:10.3390/gels12111050

BibTeX
@article{Ruocco2026,
  author = {Ruocco, Federica and Sánchez-Guirales, Sergio A. and Fernández-García, Raquel and Romero, Alejandro and Juberías, Antonio and Serrano, Dolores R. and Torrado, Juan J.},
  title = {Formulation Matters: How Cream Architecture Governs High-Dose Topical Melatonin},
  journal = {Gels},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {1050},
  doi = {10.3390/gels12111050}
}
Kostenlos starten →